Cutting the Cost of Clinical Research: The Solution Comes from Russia,…

Xtalks presents an exciting live webinar on Monday, February 25, 2013 at 11:00am EST on developing potency assays for validation. Join experts from Synergy Research – Dr. Sergei Varshavsky and Mr….

(PRWeb February 05, 2013)

Read the full story at

Drug Patent Expirations for Jan 13 2013

If your reader cannot render the information below, go to to see the latest expirations

Journal of Commercial Biotechnology


This newsletter is
a free service of DrugPatentWatch

DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents

Drug Patent Expirations for January 13 2013

TradenameApplicantGeneric Name Patent
LOTRONEXPrometheus Labsalosetron hydrochlorideJan 13, 2013

*Drugs may be
covered by multiple patents or regulatory protections. See the DrugPatentWatch
database for complete details.


Future drug patent expirations by month

Patent Expirations by

infographics &raquo

DrugPatentWatch Serves Your Competitive Intelligence

Subscribers have
access to valuable datasets, including:
  • Patent litigation
  • Clinical trial information
  • International patent families
  • International patent priority and PCT
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Drug Master Files
  • Dynamic search capabilities with data
  • More…
See the Database
and Plan
. Contact Us with any

The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details

Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or

OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)

Visit booth #39 to see how OpenClinica enhances clinical trial productivity while enabling greater freedom and control over your technology.(PRWeb February 05, 2013)Read the full story at

Medical Device Veteran and Author, Rudy Mazzocchi is Honored as One of…

As Chief Executive Officer of ELENZA, Inc., Mazzocchi was selected as one of this year’s Top Innovators in the field of Life Sciences, and will present at the upcoming Venture Summit West…

(PRWeb February 05, 2013)

Read the full story at

BioPharm Systems to Host Webinar on Clinical Trial Supply Management…

This free one-hour webinar will discuss how Oracle’s Siebel Clinical Trial Management System (CTMS) can be used for clinical trial supply and inventory management.

(PRWeb February 05, 2013)

Read the full story at

Oracle’s Value Chain Summit San Francisco: Track Sponsor NexInfo…

After the success of the Clinical Trials Operations Planning solution specific to the planning and management of Clinical Trials for the pharmaceuticals industry NexInfo now launches the Project…(PRWeb February 04, 2013)Read the full story at http…

Which pharmaceutical companies face the most patent expirations this year?

This infographic from DrugPatentWatch shows that Sanofi Aventis, Merck, and GlaxoSmithKline face the most patent expirations this year. Perhaps not surprisingly, GlaxoSmithKline and Sanofi Aventis are also among the firms with the most drug patents. For more infographics, see the DrugPatentWatch Pharmaceutical Innovation Infographics. Do you have a response to this infographic? Respond in the comments […]

Secretary of Department of Environmental Protection, Michael Krancer,…

The Pittcon 2013 Organizing Committee is pleased to announce that the Secretary of the Department of Environmental Protection, Michael Krancer, will facilitate the Conferee Networking Session, “The…

(PRWeb February 04, 2013)

Read the full story at

Infinata’s BioPharm Insight™ Achieves Record Growth in 2012

Secures position as thought leader in the healthcare community through educational webinars, new product enhancements and forward-looking journalism.(PRWeb February 04, 2013)Read the full story at

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: